Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆.
Wu XH, Zhu JQ, Yin RT, Yang JX, Liu JH, Wang J, Wu LY, Liu ZL, Gao YN, Wang DB, Lou G, Yang HY, Zhou Q, Kong BH, Huang Y, Chen LP, Li GL, An RF, Wang K, Zhang Y, Yan XJ, Lu X, Lu WG, Hao M, Wang L, Cui H, Chen QH, Abulizi G, Huang XH, Tian XF, Wen H, Zhang C, Hou JM, Mirza MR. Wu XH, et al. Among authors: yin rt. Ann Oncol. 2021 Apr;32(4):512-521. doi: 10.1016/j.annonc.2020.12.018. Epub 2021 Jan 14. Ann Oncol. 2021. PMID: 33453391 Free article. Clinical Trial.
Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective study.
Zhang X, Yuan C, Xiao X, Yin R, Lei H, Li Y, Zheng S, Wen S, Li D, Wang X, Lu Z, Zhang Y, Zeng W, He S, Li Y, Jian D, Yang J, Zhong H, Han D, Chen X, Zhou J, Cai Y, Peng X, Li Z, Liu X, Lin T, Zhang R, Li G, Zhuang Y, Liu L, Yan Y, Wang B. Zhang X, et al. Among authors: yin r. Photodiagnosis Photodyn Ther. 2023 Jun;42:103545. doi: 10.1016/j.pdpdt.2023.103545. Epub 2023 Mar 29. Photodiagnosis Photodyn Ther. 2023. PMID: 37001715 Free article.
Corrigendum to "Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective study" [Photodiagnosis Photodyn Ther. 2023 Jun;42:103545].
Zhang X, Yuan C, Xiao X, Yin R, Lei H, Li Y, Zheng S, Wen S, Li D, Wang X, Lu Z, Zhang Y, Zeng W, He S, Li Y, Jian D, Yang J, Zhong H, Han D, Chen X, Zhou J, Cai Y, Peng X, Li Z, Liu X, Lin T, Zhang R, Li G, Zhuang Y, Liu L, Yan Y, Wang B. Zhang X, et al. Among authors: yin r. Photodiagnosis Photodyn Ther. 2024 Feb;45:103931. doi: 10.1016/j.pdpdt.2023.103931. Epub 2023 Dec 26. Photodiagnosis Photodyn Ther. 2024. PMID: 38151442 Free article. No abstract available.
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial.
Wu X, Zhu J, Yin R, Yang J, Liu J, Wang J, Wu L, Liu Z, Gao Y, Wang D, Lou G, Yang H, Zhou Q, Kong B, Huang Y, Chen L, Li G, An R, Wang K, Zhang Y, Yan X, Lu X, Lu W, Hao M, Wang L, Cui H, Chen Q, Abulizi G, Huang X, Tian X, Wen H, Huang Z, Dong J, Zhang C, Hou J, Mirza MR. Wu X, et al. Among authors: yin r. EClinicalMedicine. 2024 May 7;72:102629. doi: 10.1016/j.eclinm.2024.102629. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745967 Free PMC article.
2,041 results